Cole Jason

CIK 00013503601 companyCAMBRIDGE, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001350360

Recent Transactions

19 trades

Sale
EPIRUS Biopharmaceuticals, Inc.
Common Stock
2012-01-27$1.09/sh−2,420→ 15,086 total
Exercise/Conversion
EPIRUS Biopharmaceuticals, Inc.
Common Stock
2011-06-09$1.07/sh+70,948→ 82,204 total
Exercise/Conversion
EPIRUS Biopharmaceuticals, Inc.
Stock Option (Right to Buy)
2011-06-09−47,620→ 0 total
Exercise/Conversion
EPIRUS Biopharmaceuticals, Inc.
Stock Option (Right to Buy)
2011-06-09−18,416→ 8,371 total
Exercise/Conversion
EPIRUS Biopharmaceuticals, Inc.
Stock Option (Right to Buy)
2011-06-09−75→ 7,738 total
Exercise/Conversion
EPIRUS Biopharmaceuticals, Inc.
Stock Option (Right to Buy)
2011-06-09−54,687→ 295,313 total
Exercise/Conversion
EPIRUS Biopharmaceuticals, Inc.
Common Stock
2011-06-09$0.95/sh+54,687→ 65,943 total
Sale
EPIRUS Biopharmaceuticals, Inc.
Common Stock
2011-06-09$2.33/sh−70,948→ 11,256 total
Sale
EPIRUS Biopharmaceuticals, Inc.
Common Stock
2011-06-09$2.33/sh−54,687→ 11,256 total
Exercise/Conversion
EPIRUS Biopharmaceuticals, Inc.
Stock Option (Right to Buy)
2011-06-09−4,837→ 1,117 total
Sale
EPIRUS Biopharmaceuticals, Inc.
Common Stock
2011-06-09$2.33/sh−70,948→ 11,256 total
Exercise/Conversion
EPIRUS Biopharmaceuticals, Inc.
Common Stock
2011-06-09$0.95/sh+54,687→ 65,943 total
Exercise/Conversion
EPIRUS Biopharmaceuticals, Inc.
Stock Option (Right to Buy)
2011-06-09−47,620→ 0 total
Exercise/Conversion
EPIRUS Biopharmaceuticals, Inc.
Stock Option (Right to Buy)
2011-06-09−75→ 7,738 total
Sale
EPIRUS Biopharmaceuticals, Inc.
Common Stock
2011-06-09$2.33/sh−54,687→ 11,256 total
Exercise/Conversion
EPIRUS Biopharmaceuticals, Inc.
Stock Option (Right to Buy)
2011-06-09−18,416→ 8,371 total
Exercise/Conversion
EPIRUS Biopharmaceuticals, Inc.
Stock Option (Right to Buy)
2011-06-09−54,687→ 295,313 total
Exercise/Conversion
EPIRUS Biopharmaceuticals, Inc.
Stock Option (Right to Buy)
2011-06-09−4,837→ 1,117 total
Exercise/Conversion
EPIRUS Biopharmaceuticals, Inc.
Common Stock
2011-06-09$1.07/sh+70,948→ 82,204 total

Companies

EPIRUS Biopharmaceuticals, Inc.
SVP & General Counsel

Recent Filings

Address

C/O ZALICUS INC. 245 FIRST STREET, 3RD FLOOR

CAMBRIDGE, MA, 02142

View on SEC.gov